BRAINLIFE.ORG





Current Neuro-Oncology




Volume 26 Number 26
20 November 2024




Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 26, 20 November






Cozzens JW, Lokaitis BC, Delfino K, Hoeft A, Moore BE, Fifer AS, Amin DV, Espinosa JA, Jones BA, Acakpo-Satchivi L.
A Phase 2 Sensitivity and Selectivity Study of High-Dose 5-Aminolevulinic Acid in Adult Patients Undergoing Resection of a Newly Diagnosed or Recurrent Glioblastoma.
Oper Neurosurg (Hagerstown). 2024 Nov 11. doi: 10.1227/ons.0000000000001417. PMID: 39526779. Interventional study˰ ˍ




*El-Hajj VG, Ranganathan S, Hoang H, Ghaith AK, Bydon M, Elmi-Terander A.
The impact of adjuvant radiotherapy on overall survival in spinal low-grade gliomas: a propensity score-matched analysis.
J Neurooncol. 2024 Nov 11. doi: 10.1007/s11060-024-04880-3. PMID: 39527384. Observational study. ˍ




Gdynia HJ, Schneiderat P, Gratzer A, Wiedhopf K, Gdynia N, Haase I.
Clinical features and rehabilitation outcome after surgical treatment of spinal meningioma.
Spinal Cord Ser Cases. 2024 Nov 11;10(1):75. doi: 10.1038/s41394-024-00688-5. PMID: 39528486. Observational study˰ ˍ




Kanamori M, Shibahara I, Shimoda Y, Akiyama Y, Beppu T, Ohba S, Enomoto T, Ono T, Mitobe Y, Hanihara M, Mineharu Y, Ishida J, Asano K, Yoshida Y, Natsumeda M, Nomura S, Abe T, Yonezawa H, Katakura R, Shibui S, Kuroiwa T, Suzuki H, Takei H, Matsushita H, Saito R, Arakawa Y, Sonoda Y, Hirose Y, Kumabe T, Yamaguchi T, Endo H, Tominaga T.
Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection.
Int J Clin Oncol. 2024 Nov 11. doi: 10.1007/s10147-024-02650-9. PMID: 39527165. Interventional study. ˍ




*Puranik AD, Dev ID, Rangarajan V, Jain Y, Patra S, Purandare NC, Sahu A, Choudhary A, Bhattacharya K, Gupta T, Chatterjee A, Dasgupta A, Moiyadi A, Shetty P, Singh V, Sridhar E, Sahay A, Shah A, Menon N, Ghosh S, Choudhury S, Shah S, Agrawal A, Lakshminarayanan N, Kumar A, Gopalakrishna A.
FET PET to differentiate between post-treatment changes and recurrence in high-grade gliomas: a single center multidisciplinary clinic controlled study.
Neuroradiology. 2024 Nov 11. doi: 10.1007/s00234-024-03495-9. PMID: 39527264. Observational study. ˍ




*Wee CW, Lee JH, Lee HI, Kim J, Chang JH, Kang SG, Kim EH, Moon JH, Cho J, Park CK, Kim CY, Hwang K, Yoon HI, Kim IA.
To Use or Not to Use: Temozolomide in Elderly Patients with IDH Wild-type MGMT Promoter Unmethylated Glioblastoma Treated with Radiotherapy.
Cancer Res Treat. 2024 Nov 11. doi: 10.4143/crt.2024.945. PMID: 39529389. Observational study. ˍ




Johnstad C, Reinertsen I, Thurin E, Dunås T, Bouget D, Sagberg LM, Jakola AS, Solheim O.
The prognostic importance of glioblastoma size and shape.
Acta Neurochir (Wien). 2024 Nov 12;166(1):450. doi: 10.1007/s00701-024-06351-0. PMID: 39531176. Observational study. ˍ




Berghaus N, Hielscher T, Savran D, Schrimpf D, Maas SLN, Preusser M, Weller M, Acker T, Herold-Mende C, Wick W, von Deimling A, Sahm F.
Meningiomas: Sex-Specific Differences and Prognostic Implications of a Chromosome X Loss.
Neuro Oncol. 2024 Nov 13:noae239. doi: 10.1093/neuonc/noae239. PMID: 39535060. Observational study; Laboratory investigation˰ ˍ




Bonaventure A, Simpson J, Kane E, Roman E.
Maternal illnesses during pregnancy and the risk of childhood cancer: A medical-record based analysis (UKCCS).
Int J Cancer. 2024 Nov 13. doi: 10.1002/ijc.35166. PMID: 39535336. Observational study. ˍ




Monje M, Mahdi J, Majzner R, Yeom KW, Schultz LM, Richards RM, Barsan V, Song KW, Kamens J, Baggott C, Kunicki M, Rietberg SP, Lim AS, Reschke A, Mavroukakis S, Egeler E, Moon J, Patel S, Chinnasamy H, Erickson C, Jacobs A, Duh AK, Tunuguntla R, Klysz DD, Fowler C, Green S, Beebe B, Carr C, Fujimoto M, Brown AK, Petersen AG, McIntyre C, Siddiqui A, Lepori-Bui N, Villar K, Pham K, Bove R, Musa E, Reynolds WD, Kuo A, Prabhu S, Rasmussen L, Cornell TT, Partap S, Fisher PG, Campen CJ, Grant G, Prolo L, Ye X, Sahaf B, Davis KL, Feldman SA, Ramakrishna S, Mackall C.
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas.
Nature. 2024 Nov 13. doi: 10.1038/s41586-024-08171-9. PMID: 39537919. Interventional study. ˍ




Petitt JC, Murayi R, El-Abtah ME, Momin A, Halima A, Potter T, Ahorukomeye P, Jarmula J, Thapliyal M, Murphy ES, Chao ST, Suh JH, Recinos PF, Kshettry VR.
Outcomes of adjuvant radiation treatment following subtotal resection of world health organization grade II meningiomas.
J Neurooncol. 2024 Nov 13. doi: 10.1007/s11060-024-04878-x. PMID: 39538039. Observational study˰ ˍ




Hovman FR, Poulsen FR, Hansen S, Dahlrot RH.
The risk of venous thromboembolism in adult patients with diffuse glioma: a nationwide population-based study.
Acta Oncol. 2024 Nov 14;63:887-892. doi: 10.2340/1651-226X.2024.40137. PMID: 39543846. Observational study. ˍ




Tini P, Cinelli E, Yavorska M, Donnini F, Marampon F, Pastina P, Rubino G, Chibbaro S, Cerase A, Mazzei MA, Di Giacomo AM, Minniti G.
Serum lactate dehydrogenase as a prognostic marker for treatment response in IDH wild-type glioblastoma patients undergoing stupp protocol.
J Neurooncol. 2024 Nov 14. doi: 10.1007/s11060-024-04862-5. PMID: 39540980. Observational study˰ ˍ




Atsukawa N, Tatekawa H, Ueda D, Oura T, Matsushita S, Horiuchi D, Takita H, Mitsuyama Y, Baba R, Tsukamoto T, Shimono T, Miki Y.
Visualizing the association between the location and prognosis of isocitrate dehydrogenase wild-type glioblastoma: a voxel-wise Cox regression analysis with open-source datasets.
Neuroradiology. 2024 Nov 15. doi: 10.1007/s00234-024-03503-y. PMID: 39542911. Observational study˰ ˍ








Rafaelian AA, Martynov BV, Chemodakova KA, Kholyavin AI, Martynov RS, Klimenkova EY, Prokudin MY, Papayan GV, Boykov IV, Svistov DV.
Stereotactic Photodynamic Therapy of Recurrent Malignant Gliomas.
Sovrem Tekhnologii Med. 2024 Apr 27;16(2):58-65. doi: 10.17691/stm2024.16.2.06. PMID: 39539750. Observational study. ˍ




Padilla H, Liu MD, Hass RM, Carabenciov ID, Mustafa R.
Primary Diffuse Leptomeningeal Gliomatosis.
Neurohospitalist. 2024 Sep 27:19418744241289169. doi: 10.1177/19418744241289169. PMID: 39544271. Case report. ˍ




Fang Z, Shu T, Luo P, Shao Y, Lin L, Tu Z, Zhu X, Wu L.
The peritumoral edema index and related mechanisms influence the prognosis of GBM patients.
Front Oncol. 2024 Oct 29;14:1417208. doi: 10.3389/fonc.2024.1417208. PMID: 39534094. Observational study. ˍ




Pepper NB, Prange NG, Troschel FM, Kröger K, Oertel M, Kuhlmann T, Müther M, Grauer O, Stummer W, Eich HT.
Efficacy and Low Toxicity of Normo-Fractionated Re-Irradiation with Combined Chemotherapy for Recurrent Glioblastoma-An Analysis of Treatment Response and Failure.
Cancers (Basel). 2024 Oct 29;16(21):3652. doi: 10.3390/cancers16213652. PMID: 39518091. Observational study. ˍ




Rybka L, Jonkers R, Burzlaff M, Rosenstock T, Vajkoczy P, Picht T, Faust K, Rofes A.
Preoperative subjective impairments in language and memory in brain tumor patients.
Front Oncol. 2024 Oct 29;14:1475860. doi: 10.3389/fonc.2024.1475860. PMID: 39534098. Observational study. ˍ




Aboubechara JP, Aboud O.
Metabolic Risk Factors and Survival in Patients with Glioblastoma.
Cancers (Basel). 2024 Oct 30;16(21):3666. doi: 10.3390/cancers16213666. PMID: 39518104. Observational study. ˍ




Leonetti A, Puglisi G, Rossi M, Viganò L, Conti Nibali M, Gay L, Sciortino T, Fornia L, Cerri G, Bello L.
Sexual life in adults treated for brain tumors: a retrospective study.
Front Oncol. 2024 Oct 30;14:1483697. doi: 10.3389/fonc.2024.1483697. PMID: 39540150. Observational study. ˍ




Song Y, Go KO.
Clinical Experiences Using CyberKnife for Large-Volume Meningiomas: A Preliminary Study.
Brain Tumor Res Treat. 2024 Oct 31;12(4):230-236. doi: 10.14791/btrt.2024.0030. PMID: 39542519. Observational study. ˍ




Pehlivan UA, Aktekin EH, Yalcin C, Hasbay B, Gunesli A, Alkan O.
Diagnostic Utility of Diffusion-Weighted Imaging in Distinguishing Common Pediatric Posterior Fossa Tumors: A Single Center Retrospective Study.
Turk Arch Pediatr. 2024 Nov 1;59(6):560-566. doi: 10.5152/TurkArchPediatr.2024.24154. PMID: 39540776. Observational study. ˍ




Li Y, Zheng Z, He Q.
Individualized Prediction of Overall Survival Time for Patients with Primary Intramedullary Spinal Cord Astrocytoma: A Population-Based Study.
World Neurosurg. 2024 Nov 5:S1878-8750(24)01796-0. doi: 10.1016/j.wneu.2024.10.092. PMID: 39510174. Observational study˰ ˍ




Xie XP, Ganbold M, Li J, Lien M, Chipman ME, Wang T, Jayewickreme CD, Pedraza AM, Bale T, Tabar V, Brennan C, Sun D, Sharma R, Parada LF.
Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrence.
Neuron. 2024 Nov 6:S0896-6273(24)00733-5. doi: 10.1016/j.neuron.2024.10.012. PMID: 39510072. Laboratory investigation˰ ˍ




Reihanian Z, Abbaspour E, Zaresharifi N, Karimzadhagh S, Mahmoudalinejad M, Sourati A, Farzin M, EslamiKenarsari H.
Impact of Age and Gender on Survival of Glioblastoma Multiforme Patients: A Multicenter Retrospective Study.
Cancer Rep (Hoboken). 2024 Nov 7;7(11):e70050. doi: 10.1002/cnr2.70050. PMID: 39506810. Observational study. ˍ




Zeng M, Zheng M, Wang J, Li S, Ji N, Peng Y.
Effect of perioperative dexmedetomidine on postoperative delirium in patients with brain tumours: a protocol of a randomised controlled trial.
BMJ Open. 2024 Nov 7;14(11):e084380. doi: 10.1136/bmjopen-2024-084380. PMID: 39515867. Interventional study protocol. ˍ




Frosina G, Casella C, Puppo A, Marani E, Campanella D, Boni L, Fontana V.
Epidemiology of malignant brain tumors in Genova, Italy. 1993-2017.
Sci Rep. 2024 Nov 8;14(1):27300. doi: 10.1038/s41598-024-79170-z. PMID: 39516674. Observational study. ˍ




Iwamoto FM, Tanguturi SK, Nayak L, Wang TJ, Desai A, Lustig RA, Bagley S, Wong ET, Hertan LM, McCluskey C, Hayden J, Muzikansky A, Nakhawa S, Japo J, Bossi CC, Meylan M, Tian Y, Barlow GL, Speliakos P, Ayoub G, Meredith DM, Ligon KL, Haas-Kogan D, Huang K, Wucherpfennig KW, Wen PY, Reardon DA.
Re-irradiation plus pembrolizumab: Phase II study for recurrent glioblastoma patients.
Clin Cancer Res. 2024 Nov 8. doi: 10.1158/1078-0432.CCR-24-1629. PMID: 39513953. Interventional study˰ ˍ




Ning W, Qian X, Dunmall LC, Liu F, Guo Y, Li S, Song D, Liu D, Ma L, Qu Y, Wang H, Gu C, Zhang M, Wang Y, Wang S, Zhang H.
Non-secreting IL12 expressing oncolytic adenovirus Ad-TD-nsIL12 in recurrent high-grade glioma: a phase I trial.
Nat Commun. 2024 Nov 8;15(1):9299. doi: 10.1038/s41467-024-53041-7. PMID: 39516192. Interventional study. ˍ




Qiao X, Wang Z, Chen Y, Peng N, Zhang H, Niu C, Cheng C.
Combined metformin and simvastatin therapy inhibits SREBP2 maturation and alters energy metabolism in glioma.
Cell Death Dis. 2024 Nov 9;15(11):809. doi: 10.1038/s41419-024-07169-5. PMID: 39521788. Laboratory investigation. ˍ